JO
NAGE

John Overdeck’s Niagen Bioscience NAGE Stock Holding History

John Overdeck’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-169,131
Closed -$1.08M – 5016
2025
Q4 		$1.08M Buy
+169,131
New +$1.18M ﹤0.01% 2861
2025
Q2 		– Sell
-38,393
Closed -$265K – 3656
2025
Q1 		$265K Sell
38,393
-88,905
-70% -$559K ﹤0.01% 2758
2024
Q4 		$675K Buy
+127,298
New +$697K ﹤0.01% 2392
2023
Q4 		– Sell
-11,183
Closed -$16.3K – 3427
2023
Q3 		$16.3K Hold
11,183
– – ﹤0.01% 2881
2023
Q2 		$17.6K Sell
11,183
-4,200
-27% -$6.27K ﹤0.01% 2917
2023
Q1 		$23.5K Sell
15,383
-61,467
-80% -$109K ﹤0.01% 2837
2022
Q4 		$129K Buy
76,850
+29,925
+64% +$47.4K ﹤0.01% 2473
2022
Q3 		$58K Sell
46,925
-124,672
-73% -$201K ﹤0.01% 2303
2022
Q2 		$287K Buy
171,597
+25,907
+18% +$50.7K ﹤0.01% 2041
2022
Q1 		$358K Sell
145,690
-41,721
-22% -$114K ﹤0.01% 2154
2021
Q4 		$701K Buy
187,411
+93,429
+99% +$504K ﹤0.01% 2902
2021
Q3 		$589K Buy
93,982
+1,461
+2% +$12K ﹤0.01% 3101
2021
Q2 		$912K Sell
92,521
-195,234
-68% -$1.7M ﹤0.01% 2559
2021
Q1 		$2.69M Buy
287,755
+222,144
+339% +$1.76M 0.01% 1478
2020
Q4 		$315K Sell
65,611
-12,095
-16% -$59K ﹤0.01% 2829
2020
Q3 		$312K Sell
77,706
-67,112
-46% -$324K ﹤0.01% 2561
2020
Q2 		$665K Buy
+144,818
New +$648K ﹤0.01% 1801
2018
Q1 		– Sell
-24,668
Closed -$145K – 3587
2017
Q4 		$145K Buy
+24,668
New +$133K ﹤0.01% 2970

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

John Overdeck's NAGE Position: Q1 2026 in Review

John Overdeck sold out of Niagen Bioscience (NAGE) in Q1 2026, closing a stake of 169,131 shares — an estimated $1.08M sold.

John Overdeck first reported a position in NAGE in Q4 2017 and held it in 18 quarters. The position peaked at $2.69M in Q1 2021. 143 funds tracked by Wall St. Rank hold NAGE as of Q1 2026.

  • John Overdeck reported no remaining Niagen Bioscience position as of Q1 2026 after selling out during the quarter.
  • John Overdeck sold 169,131 Niagen Bioscience shares in Q1 2026, an estimated $1.08M.
  • John Overdeck first reported a position in Niagen Bioscience in Q4 2017 and held it in 18 quarters.
  • John Overdeck's Niagen Bioscience position peaked at $2.69M in Q1 2021.
  • 143 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.